RxDoctor Payments Data

Lee van Houten-Sauter, DO

Family Medicine · Williamstown, NJNPI 1508869553

Payments from drug & device makers

$9,148in general payments, 2019–2025

Across 575 payments — averaging $15.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AstraZeneca$862
  • AbbVie$752
  • Pfizer$610
  • Lilly USA, LLC$550
  • Amgen$533
  • plus $4K from 43 others

What the payments were for

  • Food & beverage$9,116100%
  • Education$320%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,148 in reported general payments places this provider in the 90th percentile of 2,084 family medicine providers in New Jersey.

See all family medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$257,850
Medicare patients
350
Services billed
4,502

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide56$117,587
FarxigaDapagliflozin Propanediol73$74,372
OzempicSemaglutide54$73,256
TrulicityDulaglutide33$63,306
EliquisApixaban45$57,396
JanuviaSitagliptin Phosphate35$49,364
RybelsusSemaglutide29$46,561
XareltoRivaroxaban51$42,818
JardianceEmpagliflozin29$36,384
JanumetSitagliptin Phos/Metformin Hcl24$27,494
Tresiba Flextouch U-200Insulin Degludec17$21,765
MyrbetriqMirabegron20$18,817
SynthroidLevothyroxine Sodium133$13,395
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate16$5,333
Rosuvastatin Calcium263$4,975

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$550$180,89389 claims
Novo NordiskOzempic, Rybelsus$1,669$119,81783 claims
MerckJanuvia, Janumet$117$76,85859 claims
AstraZenecaFarxiga$862$74,37273 claims
PfizerEliquis$610$57,39645 claims
Johnson & JohnsonXarelto$210$42,81851 claims
Boehringer IngelheimJardiance$325$36,38429 claims
Astellas Pharma US IncMyrbetriq$160$18,81720 claims
AbbVieSynthroid$752$13,395133 claims
GSKArnuity Ellipta$423$4,79111 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$15$2,481247 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,084 family medicine providers in New Jersey.

Other family medicine in Williamstown

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →